Biotricity (OTC:BTCY) reported quarterly losses of $(0.03) per share. This is a 61.33 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $3.874 million which beat the analyst consensus estimate of $3.800 million by 1.95 percent. This is a 20.99 percent increase over sales of $3.202 million the same period last year.